BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28640361)

  • 21. Global metabolomics profiling of colorectal cancer in Malaysian patients.
    Amir Hashim NA; Ab-Rahim S; Wan Ngah WZ; Nathan S; Ab Mutalib NS; Sagap I; A Jamal AR; Mazlan M
    Bioimpacts; 2021; 11(1):33-43. PubMed ID: 33469506
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabonomics identifies serum metabolite markers of colorectal cancer.
    Tan B; Qiu Y; Zou X; Chen T; Xie G; Cheng Y; Dong T; Zhao L; Feng B; Hu X; Xu LX; Zhao A; Zhang M; Cai G; Cai S; Zhou Z; Zheng M; Zhang Y; Jia W
    J Proteome Res; 2013 Jun; 12(6):3000-9. PubMed ID: 23675754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploratory metabolomic study to identify blood-based biomarkers as a potential screen for colorectal cancer.
    Asante I; Pei H; Zhou E; Liu S; Chui D; Yoo E; Conti DV; Louie SG
    Mol Omics; 2019 Feb; 15(1):21-29. PubMed ID: 30515501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of colorectal neoplasia by using serum bile acid profile.
    Uchiyama K; Naito Y; Yagi N; Mizushima K; Higashimura Y; Hirai Y; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Ishikawa T; Takagi T; Konishi H; Kuriu Y; Nakanishi M; Otsuji E; Honda A; Itoh Y
    Biomarkers; 2021 Jul; 26(5):462-467. PubMed ID: 33926316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
    Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
    J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression.
    Aherne ST; Madden SF; Hughes DJ; Pardini B; Naccarati A; Levy M; Vodicka P; Neary P; Dowling P; Clynes M
    BMC Cancer; 2015 Apr; 15():329. PubMed ID: 25924769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention.
    Guo X; Wang R; Chen R; Zhang Z; Wang J; Liu X
    Clin Chim Acta; 2024 Jun; 560():119732. PubMed ID: 38772522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
    Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum triglyceride predicts recurrence of colorectal polyps in patients with advanced adenomas.
    Liu B; Wen P; Gu X; Weng R; Liu S
    Lipids Health Dis; 2020 Sep; 19(1):211. PubMed ID: 32967679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring Metabolic Profile Differences between Colorectal Polyp Patients and Controls Using Seemingly Unrelated Regression.
    Chen C; Deng L; Wei S; Nagana Gowda GA; Gu H; Chiorean EG; Abu Zaid M; Harrison ML; Pekny JF; Loehrer PJ; Zhang D; Zhang M; Raftery D
    J Proteome Res; 2015 Jun; 14(6):2492-9. PubMed ID: 25919433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein and risk of colorectal adenomas or serrated polyps: a prospective study.
    Crockett SD; Mott LA; Barry EL; Figueiredo JC; Burke CA; Baxter GJ; Sandler RS; Baron JA
    Cancer Prev Res (Phila); 2014 Nov; 7(11):1122-7. PubMed ID: 25145487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
    Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
    Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
    Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
    Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of urinary biomarkers of colorectal cancer: Towards the development of a colorectal screening test in limited resource settings.
    Zhang L; Zheng J; Ismond KP; MacKay S; LeVatte M; Constable J; Isaac Alatise O; Peter Kingham T; Wishart DS
    Cancer Biomark; 2023; 36(1):17-30. PubMed ID: 35871322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal Metabolome in Hmga1 Transgenic Mice with Polyposis: Evidence for Potential Screen for Early Detection of Precursor Lesions in Colorectal Cancer.
    Williams MD; Xian L; Huso T; Park JJ; Huso D; Cope LM; Gang DR; Siems WF; Resar L; Reeves R; Hill HH
    J Proteome Res; 2016 Dec; 15(12):4176-4187. PubMed ID: 27696867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue amino acid profile could be used to differentiate advanced adenoma from colorectal cancer.
    Gao P; Zhou C; Zhao L; Zhang G; Zhang Y
    J Pharm Biomed Anal; 2016 Jan; 118():349-355. PubMed ID: 26595283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct Metabolic Profiles are Associated with Colorectal Adenomas and Serrated Polyps.
    Fliss-Isakov N; Zelber-Sagi S; Webb M; Halpern Z; Shibolet O; Kariv R
    Obesity (Silver Spring); 2017 Nov; 25 Suppl 2():S72-S80. PubMed ID: 29086511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.
    Yao L; Lao W; Zhang Y; Tang X; Hu X; He C; Hu X; Xu LX
    J Proteome Res; 2012 Jun; 11(6):3281-94. PubMed ID: 22506683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.